Pulmonary embolism risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 39: | Line 39: | ||
'''Risk Factors Identified in the PIOPED Study'''<ref name="pmid8523135">{{cite journal| author=Worsley DF, Alavi A| title=Comprehensive analysis of the results of the PIOPED Study. Prospective Investigation of Pulmonary Embolism Diagnosis Study. | journal=J Nucl Med | year= 1995 | volume= 36 | issue= 12 | pages= 2380-7 | pmid=8523135 | doi= | pmc= | url= }} </ref> | '''Risk Factors Identified in the PIOPED Study'''<ref name="pmid8523135">{{cite journal| author=Worsley DF, Alavi A| title=Comprehensive analysis of the results of the PIOPED Study. Prospective Investigation of Pulmonary Embolism Diagnosis Study. | journal=J Nucl Med | year= 1995 | volume= 36 | issue= 12 | pages= 2380-7 | pmid=8523135 | doi= | pmc= | url= }} </ref> | ||
Independent risk factors identified in ''prospective investigation of pulmonary embolism diagnosis'' (PIOPED) include: | Independent risk factors identified in ''prospective investigation of pulmonary embolism diagnosis'' (PIOPED) include: | ||
* Immobilization, paresis, or [[paralysis]] | * Immobilization, [[paresis]], or [[paralysis]] | ||
* Surgery within the last 3 months | ** Travel of 4 hours or more in the past month would be considered an immobilization | ||
* History of venous thromboembolism. | * Surgery within the last 3 months or stroke | ||
* | **These may have a connection to immobilization. | ||
* History of [[venous thromboembolism]]. | |||
* Malignancies, especially lung cancer | |||
**Malignancies have been found in up to 17% of patients with an idiopathic [[deep vein thrombosis]] (DVT). | |||
* Current or past history of [[thrombophlebitis]] | * Current or past history of [[thrombophlebitis]] | ||
* Trauma to the lower extremities | * [[Trauma]] to the lower extremities or pelvis during the past 3 months | ||
* [[Smoking]] | * [[Smoking]] | ||
* Central venous instrumentation within the past 3 months | * [[Central venous instrumentation]] within the past 3 months | ||
* Prior pulmonary embolism | * Prior pulmonary embolism | ||
* [[Heart failure]] | * [[Heart failure]] | ||
* [[Chronic obstructive pulmonary disease]] | * [[Chronic obstructive pulmonary disease]] | ||
'''Risk Factors from the Nurses' Health Study'''<ref name="pmid9039882">{{cite journal| author=Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE et al.| title=A prospective study of risk factors for pulmonary embolism in women. | journal=JAMA | year= 1997 | volume= 277 | issue= 8 | pages= 642-5 | pmid=9039882 | doi= | pmc= | url= }} </ref> | '''Risk Factors from the Nurses' Health Study'''<ref name="pmid9039882">{{cite journal| author=Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE et al.| title=A prospective study of risk factors for pulmonary embolism in women. | journal=JAMA | year= 1997 | volume= 277 | issue= 8 | pages= 642-5 | pmid=9039882 | doi= | pmc= | url= }} </ref> | ||
* [[Obesity]]: RR 2.9 | * [[Obesity]]: RR (relative risk) 2.9 | ||
* [[Smoking]]: 25 – 34 cigarettes | * [[Smoking]]: | ||
**25 – 34 cigarettes per day (RR 1.9) | |||
**More than 35 cigarettes per day (RR 3.3) | |||
* [[Hypertension]]: RR 1.9 | * [[Hypertension]]: RR 1.9 | ||
* [[Oral contraceptives]]: RR | * [[Oral contraceptives]]: RR approximately 2 – 3 | ||
* [[Hormone replacement therapy]]: RR | * [[Hormone replacement therapy]]: RR approximately 2 | ||
'''Risk Factors from the Physician's Health Study'''<ref name="pmid7877648">{{cite journal| author=Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP| title=Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. | journal=N Engl J Med | year= 1995 | volume= 332 | issue= 14 | pages= 912-7 | pmid=7877648 | doi=10.1056/NEJM199504063321403 | pmc= | url= }} </ref> | '''Risk Factors from the Physician's Health Study'''<ref name="pmid7877648">{{cite journal| author=Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP| title=Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. | journal=N Engl J Med | year= 1995 | volume= 332 | issue= 14 | pages= 912-7 | pmid=7877648 | doi=10.1056/NEJM199504063321403 | pmc= | url= }} </ref> | ||
* [[Anticardiolipin antibody]] level above the 95th percentile<ref name="pmid1443986">{{cite journal| author=Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH et al.| title=Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. | journal=Ann Intern Med | year= 1992 | volume= 117 | issue= 12 | pages= 997-1002 | pmid=1443986 | doi= | pmc= | url= }} </ref>. | * [[Anticardiolipin antibody]] level above the 95th percentile<ref name="pmid1443986">{{cite journal| author=Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH et al.| title=Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. | journal=Ann Intern Med | year= 1992 | volume= 117 | issue= 12 | pages= 997-1002 | pmid=1443986 | doi= | pmc= | url= }} </ref>. | ||
* [[Factor V Leiden]] | * [[Factor V Leiden]] | ||
**RR 2.7, found in 40% of patients with idiopathic DVT. | |||
* Use of oral contraceptives by a person with the Factor V mutation increases the risk of venous thromboembolism 35 fold. | * Use of oral contraceptives by a person with the Factor V mutation increases the risk of venous thromboembolism 35 fold. | ||
* Hyperhomocysteinemia increases the risk of a DVT by | * Hyperhomocysteinemia | ||
* | **In association with Factor V increases the risk of a DVT by 10 fold. | ||
**Increases the risk of a DVT by a factor of 3. | |||
* [[Lupus anticoagulant]] was found in 8.5% of patients with idiopathic DVT. | * [[Lupus anticoagulant]] was found in 8.5% of patients with idiopathic DVT. | ||
'''Other risk factors include:''' | '''Other risk factors include:''' | ||
*[[Venous stasis]] | *[[Venous stasis]] | ||
*[[Hypercoagulable states]] | *[[Hypercoagulable states]], which can be caused by hereditary factors. | ||
*[[Pregnancy]] | *[[Pregnancy]] | ||
*[[Acute medical illness]] | *[[Acute medical illness]] | ||
*Drug abuse (intravenous [IV] drugs) | *Drug abuse (intravenous [IV] drugs) | ||
*[[Hemolytic anemias]] | *[[Hemolytic anemias]] | ||
*[[Homocystinuria]] | *[[Homocystinuria]] | ||
*Hyperlipidemias | *[[Hyperlipidemias]] | ||
*[[Phenothiazines]] | *[[Phenothiazines]] | ||
*[[Thrombocytosis]] | *[[Thrombocytosis]] | ||
*[[Varicose veins]] | *[[Varicose veins]] | ||
*[[Venography]] | *[[Venography]] | ||
*Venous pacemakers | *[[Venous pacemakers]] | ||
*[[Warfarin]] (first few days of therapy) | *[[Warfarin]] (first few days of therapy) | ||
*[[Inflammatory bowel disease]] | *[[Inflammatory bowel disease]] | ||
Revision as of 15:27, 27 April 2012
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism risk factors On the Web |
|
Directions to Hospitals Treating Pulmonary embolism risk factors |
|
Risk calculators and risk factors for Pulmonary embolism risk factors |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
The most common sources of pulmonary embolism are proximal leg deep venous thrombosis (DVTs) or pelvic vein thromboses. Any risk factor for DVT also increases the risk of pulmonary embolism, therefore DVT and PE are considered to be a continuum termed venous thromboembolism (VTE). Approximately 15% of patients with a DVT will develop a pulmonary embolus.
Risk Factors
The development of thrombosis is classically due to a group of causes referred to as Virchow's triad. Virchow's triad includes alterations in blood flow, factors in the vessel wall, and factors affecting the properties of the blood. It is common for more than one risk factor to be present.
Figure : Virchow's triad encompasses three broad categories of factors that are thought to contribute to venous thrombosis.
Medical conditions included in the triad are:
- Alterations in blood flow: Being immobile for long periods of time, as well as other strains on the body, can cause alterations in blood flow.
- Pregnancy which is a pro-coagulant
- Obesity which is also a pro-coagulant
- The immobilizations include:
- After a surgery
- injury
- Long-distance air travel
- Factors in the vessel wall:
- This is of limited direct relevance in VTE
- Factors affecting the properties of the blood (pro-coagulant state):
- Estrogen-containing hormonal contraception
- Genetic thrombophilias which include:
- Factor V Leiden
- Prothrombin mutation G20210A
- Protein C deficiency
- protein S deficiency
- Antithrombin deficiency
- Hyperhomocysteinemia
- Plasminogen/Fibrinolysis disorders
- Acquired thrombophilias which include:
Risk Factors Identified in the PIOPED Study[1] Independent risk factors identified in prospective investigation of pulmonary embolism diagnosis (PIOPED) include:
- Immobilization, paresis, or paralysis
- Travel of 4 hours or more in the past month would be considered an immobilization
- Surgery within the last 3 months or stroke
- These may have a connection to immobilization.
- History of venous thromboembolism.
- Malignancies, especially lung cancer
- Malignancies have been found in up to 17% of patients with an idiopathic deep vein thrombosis (DVT).
- Current or past history of thrombophlebitis
- Trauma to the lower extremities or pelvis during the past 3 months
- Smoking
- Central venous instrumentation within the past 3 months
- Prior pulmonary embolism
- Heart failure
- Chronic obstructive pulmonary disease
Risk Factors from the Nurses' Health Study[2]
- Obesity: RR (relative risk) 2.9
- Smoking:
- 25 – 34 cigarettes per day (RR 1.9)
- More than 35 cigarettes per day (RR 3.3)
- Hypertension: RR 1.9
- Oral contraceptives: RR approximately 2 – 3
- Hormone replacement therapy: RR approximately 2
Risk Factors from the Physician's Health Study[3]
- Anticardiolipin antibody level above the 95th percentile[4].
- Factor V Leiden
- RR 2.7, found in 40% of patients with idiopathic DVT.
- Use of oral contraceptives by a person with the Factor V mutation increases the risk of venous thromboembolism 35 fold.
- Hyperhomocysteinemia
- In association with Factor V increases the risk of a DVT by 10 fold.
- Increases the risk of a DVT by a factor of 3.
- Lupus anticoagulant was found in 8.5% of patients with idiopathic DVT.
Other risk factors include:
- Venous stasis
- Hypercoagulable states, which can be caused by hereditary factors.
- Pregnancy
- Acute medical illness
- Drug abuse (intravenous [IV] drugs)
- Hemolytic anemias
- Homocystinuria
- Hyperlipidemias
- Phenothiazines
- Thrombocytosis
- Varicose veins
- Venography
- Venous pacemakers
- Warfarin (first few days of therapy)
- Inflammatory bowel disease
References
- ↑ Worsley DF, Alavi A (1995). "Comprehensive analysis of the results of the PIOPED Study. Prospective Investigation of Pulmonary Embolism Diagnosis Study". J Nucl Med. 36 (12): 2380–7. PMID 8523135.
- ↑ Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE; et al. (1997). "A prospective study of risk factors for pulmonary embolism in women". JAMA. 277 (8): 642–5. PMID 9039882.
- ↑ Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP (1995). "Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men". N Engl J Med. 332 (14): 912–7. doi:10.1056/NEJM199504063321403. PMID 7877648.
- ↑ Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH; et al. (1992). "Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis". Ann Intern Med. 117 (12): 997–1002. PMID 1443986.